WVU TO OFFER GROUNDBREAKING IMAGING AGENT FOR LUNG CANCER DETECTION

BRIDGEPORT, W.Va. – The WVU Cancer Institute at United Hospital Center (UHC) is the first in the state to offer CYTALUX® (pafolacianine), a groundbreaking imaging agent for lung cancer detection. This innovative technology enhances a surgeons’ ability to visualize, identify, and remove cancerous tissue. Lung cancer is…





